Market Place
Sourcing Support
Celcuity Presents Gedatolisib Survival Data at SABCS 2024
11 Dec 2024 //
GLOBENEWSWIRE
Celcuity Plans Phase 3 Gedatolisib Trial Secures 62M Debt Financing
30 May 2024 //
GLOBENEWSWIRE
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
27 Mar 2024 //
GLOBENEWSWIRE
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 of Gedatolisib
22 Feb 2024 //
GLOBENEWSWIRE
Celcuity Presents Data on Therapeutic Effects of Gedatolisib in Breast Cancer
06 Dec 2023 //
GLOBENEWSWIRE
Celcuity to Present Preclinical Data for Gedatolisib
01 Dec 2023 //
GLOBENEWSWIRE
Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib
09 Dec 2022 //
ACCESSWIRE
Celcuity Announces First Patient Dosed in PIII VIKTORIA-1 Trial of Gedatolisib
07 Dec 2022 //
ACCESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.